This paper will compare the use of radiopharmaceutical used in brain death imaging in nuclear medicine. The focus is on radiopharmaceutical that cross the blood brain barrier such as Tc-99m HMPAO and Tc-99m EDC vs. Tc-99m DTPA and Tc-99m Pertechnetate. How they are different in terms of physiology and the effect of it on images and how they are interpreted (i.e. false positive and false negative studies)
– I attached some of the articles on the topic\
– This should be constructed as a research scientific article; with an abstract, introduction, methods, results and conclusion
– Column form format with pictures, graphs and tables to support information
– Some articles to use:
https://www.nucmedresource.com/brain-death-scan.html
https://www.iaea.org/inis/collection/NCLCollectionStore/_Public/29/049/29049615.pdf
https://www.snm.org/docs/brain_death_draft_v1.3.pdf
https://pharmacyce.unm.edu/nuclear_program/freelessonfiles/vol17lesson2.pdf